Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Total Debt (2016 - 2025)

INVO Fertility (IVF) has disclosed Total Debt for 12 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Debt rose 49.57% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 million, a 49.57% increase, with the full-year FY2024 number at $3.6 million, down 3.34% from a year prior.
  • Total Debt was $5.4 million for Q3 2025 at INVO Fertility, down from $6.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $6.1 million in Q1 2025 to a low of $185458.0 in Q1 2021.
  • A 4-year average of $3.2 million and a median of $3.7 million in 2024 define the central range for Total Debt.
  • Biggest YoY gain for Total Debt was 231.91% in 2024; the steepest drop was 3.34% in 2024.
  • INVO Fertility's Total Debt stood at $340539.0 in 2021, then soared by 1002.37% to $3.8 million in 2023, then dropped by 3.34% to $3.6 million in 2024, then skyrocketed by 49.81% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Total Debt are $5.4 million (Q3 2025), $6.0 million (Q2 2025), and $6.1 million (Q1 2025).